Drug Trial Radar · NCT06074562
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Last checked: Nov 20, 2026Latest source record: Jul 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
404
Actual
Start
Oct 5, 2023
Primary completion
Jun 11, 2025
Study completion Jun 11, 2025
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Oct 10, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will lasts approximately 24 weeks, across 3 study periods.
Conditions
- Diabetic Peripheral Neuropathy
Interventions
MazisotineDrug
Administered orally.
PlaceboDrug
Administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Average Pain Intensity (API) as Measured by Weekly Average of Numeric Rating Scale (NRS) - Bayesian Model Averaging (BMA) Dose-response ModelTime frame: Baseline, Week 12
- Mean Change From Baseline in Average Pain Intensity (API) as Measured by Weekly Average of Numeric Rating Scale (NRS) - Frequentist Repeated Measures (FRM) AnalysisTime frame: Baseline, Week 12
Locations
70 sites in 5 countries. Site status is shown where the registry gives one.
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona
Headlands Research - Scottsdale
Scottsdale, Arizona
Orange Grove Family Practice
Tucson, Arizona
Preferred Research Partners
Little Rock, Arkansas
Hope Clinical Research, Inc.
Canoga Park, California
Valley Clinical Trials, Inc.
Northridge, California
Northern California Research - Sacramento
Sacramento, California
CMR of Greater New Haven, LLC
Hamden, Connecticut
Suncoast Research Group
Miami, Florida
New Horizon Research Center
Miami, Florida
Northwestern University
Chicago, Illinois
Alliance for Multispecialty Research, LLC
Wichita, Kansas
Alliance for Multispecialty Research, LLC
Lexington, Kentucky
Care Access - Lake Charles
Lake Charles, Louisiana
MedVadis Research Corporation
Waltham, Massachusetts
SKY Integrative Medical Center/SKYCRNG
Ridgeland, Mississippi
StudyMetrix Research
City of Saint Peters, Missouri
Alliance for Multispecialty Research, LLC
Kansas City, Missouri
Clinvest Research LLC
Springfield, Missouri
Las Vegas Medical Research
Las Vegas, Nevada
UniMed Center
East Brunswick, New Jersey
North Suffolk Neurology
Port Jefferson Station, New York
Lucas Research - Hickory
Hickory, North Carolina
Lucas Research, Inc
Morehead City, North Carolina
Velocity Clinical Research, Medford
Medford, Oregon
Tristar Clinical Investigations
Philadelphia, Pennsylvania
Suburban Research Associates
West Chester, Pennsylvania
New Phase Research and Development
Knoxville, Tennessee
FutureSearch Trials of Neurology
Austin, Texas
Juno Research
Houston, Texas
Consano Clinical Research, LLC
Shavano Park, Texas
Velocity Clinical Research, Salt Lake City
West Jordan, Utah
Northwest Clinical Research Center
Bellevue, Washington
Rainier Clinical Research Center
Renton, Washington
Agentura Science Pro
Olomouc, Czechia
EDUMED - Broumov
Broumov, Hradec Králové Region, Czechia
Diabet2 s.r.o., diabetologicka a interni ambulance
Prague, Praha 1, Czechia
Neurologická Ambulance - Forbeli
Prague, Praha 6, Czechia
DiaVize s.r.o.
Prague, Praha, Hlavní Mešto, Czechia
FLEDIP - Na dlouhem lanu
Prague, Praha, Hlavní Mešto, Czechia
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.